$239.00 Original price was: $239.00.$63.00Current price is: $63.00.
Authored by Lorenzo Galluzzi, “Immune Checkpoint Biology in Health and Disease, Volume 382” offers in-depth reviews on the latest advancements in immune-checkpoint biology research and its implications for immunotherapy, particularly in cancer treatment.
This volume covers various topics connected to immune-checkpoint biology, including the development of novel technologies aimed at applying immune checkpoint blockers more effectively. These technologies have the potential to revolutionize cancer treatment by enhancing the body’s natural immune response to fight cancer cells.
Another key area explored in this book is the next-generation deconvolution of transcriptomic data. This approach enables researchers to investigate the tumor microenvironment in greater detail, providing valuable insights into the complex interactions between cancer cells and the surrounding immune system.
The book also delves into the role of immune checkpoints in targeting dendritic cells for antibody-based modulation in cancer. Dendritic cells play a crucial role in initiating immune responses, and understanding how to modulate them could lead to more effective cancer immunotherapies.
Furthermore, “Immune Checkpoint Biology in Health and Disease, Volume 382” discusses the interplay between immune checkpoint biology and autoimmunity in cancer patients. This knowledge is essential for developing targeted therapies that minimize adverse effects while maximizing treatment efficacy.
Recent advancements in tumor microenvironment landscaping for target selection and response prediction in immune checkpoint therapies are also addressed in the book. These advancements have been achieved through spatial protein multiplexing analysis, offering a more nuanced understanding of the complex interactions within the tumor microenvironment.
In addition, the volume covers immune modulation during anti-cancer radio(immuno)therapy. This approach combines traditional radiation therapy with immunotherapy to enhance treatment outcomes and reduce side effects.
Finally, the book explores the concept of preconditioning with immunogenic cell death-inducing treatments for subsequent immunotherapy. This strategy aims to prime the immune system to respond more effectively to cancer cells, leading to improved treatment outcomes.
“Immune Checkpoint Biology in Health and Disease, Volume 382” provides comprehensive reviews from leading experts in the field, along with useful schematic material and cutting-edge discussions. It covers the latest insights and future perspectives on immune checkpoint biology and its implications for immunology and immunotherapy, as well as clinical perspectives.
Language | |
---|---|
Author |
Fermentum tempor cubilia risus tellus massa dis consectetur dolor.
WhatsApp Chat Oniline